Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
cbdMD, Inc. (YCBD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/11/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/11/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 07/21/2023 |
8-K
| Quarterly results |
| 05/24/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/19/2023 |
8-K
| Other Events Interactive Data |
| 05/05/2023 |
4
| Kennedy Thomas Ronan (Interim CEO and CFO) has filed a Form 4 on cbdMD, Inc.|
Txns:
| Bought 5,000 shares
@ $2.1, valued at
$10.5k
|
|
| 05/03/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/02/2023 |
10-K/A
| Annual Report for the period ended September 30, 2022 [amend] |
| 04/28/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/19/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/17/2023 |
8-K
| Other Events Interactive Data |
| 03/13/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/02/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 02/22/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events Interactive Data |
| 02/22/2023 |
4
| Raines William F III (Director) has filed a Form 4 on cbdMD, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $0.28, valued at
$8.4k
|
|
| 02/22/2023 |
4
| Sellers Bakari T. (Director) has filed a Form 4 on cbdMD, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $0.28, valued at
$8.4k
|
|
| 02/22/2023 |
4
| Stephen Scott G. (Director) has filed a Form 4 on cbdMD, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $0.28, valued at
$8.4k
|
|
| 02/22/2023 |
4
| Swift Sibyl Nichole (Director) has filed a Form 4 on cbdMD, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $0.28, valued at
$8.4k
|
|
| 02/21/2023 |
8-K
| Quarterly results |
| 02/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 01/23/2023 |
8-K
| Other Events Interactive Data |
| 01/13/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 01/04/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 01/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/23/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 12/20/2022 |
10-K/A
| Annual Report for the period ended September 30, 2022 [amend] |
| 12/16/2022 |
8-K
| Quarterly results |
|
|
|